The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.
Pharmacol Res
; 195: 106875, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37517560
Key words
Binge eating; CRF; Cholecystokinin (PubChem CID: 16129670); Leptin; Leptin (PubChem CID: 157010069); NM4-C(16) (PubChem CID: 117072559); NMU-R2; NY0116 (PubChem CID: 25020407); NY0128 (PubChem CID: 25020570); Neuromedin S (rat) (PubChem CID: 131954574); Neuromedin U; Neuromedin U-23 (Rat) (PubChem CID: 71311710); Neuromedin U-25 (human) (PubChem CID: 118708139); Obesity; α-helical Corticotropin Releasing Factor (9−41) (PubChem CID: 73931851)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuropeptides
/
Bulimia
/
Peptide Hormones
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: